Featured Articles

  1. Early Product Characterization De-Risks Biologics Development 6/12/2019

    The relationship between physicochemical profile and biological activity — and how this relationship affects clinical performance — is key to informed decisions, accelerated development, and risk reduction.

  2. Accelerating Technology Transfer Of A Drug Product 9/9/2026

    See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.

  3. A Comprehensive Solution With Targeted And Non-Targeted Approaches 8/26/2026

    Explore how non-targeted NGS and targeted molecular assays can work together during cell line characterization to provide broad virus detection while supporting evolving regulatory expectations.

  4. Targeted LNPs: From Ligand Conjugation To Process Optimization 8/20/2026

    Explore an integrated workflow for targeted lipid nanoparticle development, covering ligand conjugation, candidate screening, and scalable manufacturing for cell-specific nucleic acid delivery.

  5. Life Cycle Assessment (LCA): Empowering Sustainable Decisions 8/7/2026

    Learn how Life Cycle Assessment converts environmental data into practical insights, helping improve product development, sustainability strategies, and decision-making.

  6. Improving Bioprocessing Outcomes With The CHOZN® Elite Host Cell Line 8/7/2026

    Accelerate cell line development with a host engineered for high expression, streamlined clone selection, flexible gene integration, and scalable industrial performance.

  7. Comprehensive Characterization Strategies For Antibody-Drug Conjugates 7/24/2026

    As ADCs grow more complex and expand beyond oncology, robust characterization is essential. Learn how analytical strategies connect structure to function and identify critical quality attributes.

  8. Leveraging 3Rs For Superior Cell Line Characterization 7/13/2026

    Explore how non-animal methods, including next generation sequencing, are advancing biologics safety testing through the 3Rs while supporting faster adventitious virus testing and more.

  9. Release, Redefined: QC Testing Across In Vivo And Ex Vivo CAR-T 7/13/2026

    As CAR-T manufacturing evolves, QC strategies must adapt. Learn how identity, potency, sterility, and safety testing support faster release decisions and broader patient access.

  10. Next-Generation Filtration For Enhanced Capacity And Sustainability 7/7/2026

    Membrane design has a direct impact on throughput, formulation integrity, and sustainability. See how better filtration decisions can reduce operational bottlenecks and scale-up risk across processes.